EUVIMEDEUVIMED entdecken
Multizentrische StudieVergleichsstudieOpen Access · CC BY 4.0

Diagnostic Performance of Three Serological Assays in Myasthenia Gravis: A Prospective Multicentre Study

Laura Cuomo, Laura De Giglio, Maria Antonietta Isgrò, Maria Totaro, Matteo Pratali, Caterina Fragomeli, Lorenzo Cosmi, Francesco Annunziato, Boaz Palterer, Maria Concetta Altavista, Giovanni Antonini, Marianna Brienza und 12 weitere

Scandinavian Journal of Immunology · 2025-12 · 102 (6)

DOI: 10.1111/sji.70072 ↗

Kurz gefasst

Multizentrische Studie in der Zeitschrift Scandinavian Journal of Immunology, online erschienen am 24.11.2025. Verfasst von Laura Cuomo und 23 weiteren Autor:innen. Beteiligte Einrichtung: U.O.C. Clinical Pathology, San Filippo Neri Hospital, ASLRoma1, Rome, Italy. Hauptthemen laut MEDLINE: Myasthenia Gravis, Autoantibodies. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 17 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: LILT, Ministero dell'Università e della Ricerca.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Anti‐acetylcholine receptor (AChR) and anti‐muscle‐specific tyrosine kinase (MuSK) autoantibody detection is crucial in the diagnosis and choice of treatment of myasthenia gravis (MG). We conducted a multicentre prospective study comparing radioimmunoprecipitation assay (RIPA), enzyme‐linked immunosorbent assay (ELISA) and fixed cell‐based assay (F‐CBA) for anti‐AChR and anti‐MuSK antibody detection in 78 patients with suspected MG with at least 6 months of clinical follow‐up. In the diagnosis of seropositive MG (anti‐AChR+anti‐MuSK abs), RIPA was most sensitive (82.8%) compared to ELISA (81.0%) and F‐CBA (70.7%). F‐CBA exhibited the highest specificity overall (95.0%). For anti‐AChR detection, F‐CBA demonstrated a sensitivity of 73.6% and specificity of 95.0%; ELISA showed sensitivity and specificity of 81.1% and 85.0%, respectively; and RIPA yielded sensitivity and specificity of 81.1% and 95.0%. Sensitivity of F‐CBA improved when sera were tested at lower dilution (1:5) versus the manufacturer's recommended 1:10, without compromising specificity. Agreement among methods was almost perfect for anti‐AChR detection (Cohen's Kappa > 0.81). For anti‐MuSK detection, agreement was substantial between ELISA and RIPA, moderate between ELISA and F‐CBA, and fair between RIPA and F‐CBA. Higher anti‐AChR antibody levels were found in generalised versus ocular MG by both RIPA and ELISA. F‐CBA confirmed its optimal specificity while the sensitivity seems to be influenced by sample dilution. In conclusion, given the radioactive nature of RIPA and consequent limitations, F‐CBA may represent a valid alternative in anti‐AChR and anti‐MuSK antibody detection in MG diagnosis. We suggest that the use of live‐CBA or RIPA could be reserved for inconclusive cases.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Myasthenia GravisAutoantibodiesHumansFemaleEnzyme-Linked Immunosorbent AssayMaleProspective StudiesMiddle AgedReceptors, CholinergicAdultSensitivity and SpecificityAgedReceptor Protein-Tyrosine KinasesRadioimmunoprecipitation AssayYoung AdultAdolescentSerologic Tests

Stichwörter der Autor:innen

AChRELISAF‐CBAMuSKRIPAmyasthenia gravis

Substanzen

AutoantibodiesReceptors, CholinergicMUSK protein, humanReceptor Protein-Tyrosine Kinases

Autor:innen und Institutionen

  • U.O.C. Clinical Pathology, San Filippo Neri Hospital, ASLRoma1, Rome, Italy.
  • Neuromuscular and Rare Neurological Diseases Center, Neurology Unit, San Filippo Neri Hospital, ASLRoma1, Rome, Italy.
  • SOD Immunoallergology, AOU Careggi, Florence, Italy.
  • Department of Experimental Medicine and Clinic, Università of Florence, Florence, Italy.
  • NESMOS Department, Sapienza University of Rome and UniCamillus-St. Camillus International University of Health Science, Rome, Italy.
  • Department of Human Neurosciences, Sapienza University of Rome, Rome, Italy.

ORCID-Profile: Pankaj Trivedi

Förderung

  • LILT
  • Ministero dell'Università e della Ricerca

Zitieren

APA

Cuomo, L., De Giglio, L., Isgrò, M. A., Totaro, M., Pratali, M., Fragomeli, C., Cosmi, L., Annunziato, F., Palterer, B., Altavista, M. C., Antonini, G., Brienza, M., Cambieri, C., Cortese, F., Fionda, L., Gragnani, F., Inghilleri, M., Morino, S., Petrucci, A., …, & Pennisi, E. M. (2025). Diagnostic Performance of Three Serological Assays in Myasthenia Gravis: A Prospective Multicentre Study. Scandinavian Journal of Immunology, 102(6). https://doi.org/10.1111/sji.70072

Vancouver

Cuomo L, De Giglio L, Isgrò MA, Totaro M, Pratali M, Fragomeli C, et al. Diagnostic Performance of Three Serological Assays in Myasthenia Gravis: A Prospective Multicentre Study. Scandinavian Journal of Immunology. 2025;102(6). doi:10.1111/sji.70072

BibTeX
@article{Cuomo2025,
  author = {Cuomo, Laura and De Giglio, Laura and Isgrò, Maria Antonietta and Totaro, Maria and Pratali, Matteo and Fragomeli, Caterina and Cosmi, Lorenzo and Annunziato, Francesco and Palterer, Boaz and Altavista, Maria Concetta and Antonini, Giovanni and Brienza, Marianna and Cambieri, Chiara and Cortese, Francesca and Fionda, Laura and Gragnani, Francesca and Inghilleri, Maurizio and Morino, Stefania and Petrucci, Antonio and Piantadosi, Carlo and Anastasiadou, Eleni and Vitillo, Marina and Trivedi, Pankaj and Pennisi, Elena Maria},
  title = {Diagnostic Performance of Three Serological Assays in Myasthenia Gravis: A Prospective Multicentre Study},
  journal = {Scandinavian Journal of Immunology},
  year = {2025},
  volume = {102},
  number = {6},
  doi = {10.1111/sji.70072}
}
Kostenlos starten →